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Abstract: In this paper we present the main ideas and discuss both the feasibility and the 
conceptual design of a novel hybrid technique and equipment for an experimental cancer therapy 
based on the simultaneous and/or sequential application of two beams, namely a beam of 
neutrons and a CW (continuous wave) or intermittent sub-terahertz wave beam produced by a 
gyrotron for treatment of cancerous tumors. The main simulation tools for the development of 
the computer aided design (CAD) of the prospective experimental facility for clinical trials and 
study of such new medical technology are briefly reviewed. Some tasks for a further 
continuation of this feasibility analysis are formulated as well. 
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1. Introduction 
 
 Nowadays, the modern oncologic therapy uses various techniques for cancer treatment such as 
surgery, radiation and chemotherapy. Among them are several therapeutic techniques for neutron 
radiotherapy, namely: (i) fast neutron radiotherapy; (ii) neutron capture therapy (NCT), most 
notably BNCT (boron NCT) [1, 2]; and (iii) a combination of BNCT and a fast neutron 
radiotherapy [3]. Several other combinations are also known, such as, for example, BNCT 
supplemented by an external X-ray beam [4]. Both the advantages and the problems associated 
with these techniques are well-known and the current state-of-the-art has been reviewed recently 
in [5], where the main challenges and opportunities are discussed. Although both, reactor based 
and accelerator based, neutron sources [6] are used for production of epithermal (energy ranging 
from 1 eV to 10 keV) and thermal (energy ca 0.025 eV) neutron beams the latter are considered 
as the most appealing alternative since they can be integrated more easily and conveniently 
within the necessary medical infrastructure. Therefore, it is believed that such neutron sources 
are more preferable for a clinical implementation of the BNCT as a routine modality. Recently 
developed compact neutron sources (mini neutron tube) at Berkeley Laboratory (see for example 
[7]) have many advantageous features (small weight and dimensions; portable and highly 
scalable; safe deuterium-deuterium reaction etc.) and probably will also find application in the 
medical technologies. Similar miniature sources even allow the neutron producing target to be 
put at the end of a tiny catheter−like drift tube [8].   
 Another promising therapy is based on the irradiation by electromagnetic waves ranging from 
RF (radio frequency) to sub−terahertz frequencies (sub−millimeter waves). It is based on the 
physical and physiological action of the electromagnetic fields on the biological material, e.g. 
living tissue [9−11] through different mechanisms [12−14]. While the radiation in the optical 
region (visible light) and the infrared region interacts with the electronic levels and the molecular 
levels, respectively, the sub−millimeter waves interact with the molecular rotations. The specific 
features of the interaction of terahertz (sub-millimeter) waves with biological systems have been 
reviewed recently in [15−17]. In this spectral range, the energy of the radiation absorbed in the 
living cells is converted to a great deal into thermal energy. This process (heating) is the basis of 
two of the most widely used techniques namely the hyperthermia induced by microwave 
diathermy (in the range of 40−42 °C) and ablation (at temperatures higher than 50 °C) for 
treatment of malignant tumors. It should be noticed that the sub−millimeter wave radiation is 
non-ionizing, and, moreover the energy of a quantum (hν=1.17×10-3 eV at λ=1 mm) is even 
lower than the energy of the thermal motion at room temperature (kT=2.53×10-2 eV). One of the 
most characteristic features of the millimeter wave radiation however is its strong absorption by 
water and aqueous solutions (recall that ca 70 % of the human body is water). For example, a 
water layer of only 1 mm attenuates the wave with a length of λ=2 mm 104 times and with a 
length of λ=8 mm 100 times. Such strong absorption is due to the fact that the frequency of the 
rotational motion of water molecules is in the millimeter and sub-millimeter wave length region. 
Since the cancerous tissue usually has an increased water content the permittivity of the tumors 
is 10−30 % greater. Additionally, its conductivity is also higher than the surrounding healthy 
tissue. Thus the conditions for energy absorption in malignant cells and in the normal one is 
different, which allows a selective treatment of the former. In them, an increased temperature 
induces cellular death via coagulation necrosis and, eventually, to a tumor ablation while leaving 
intact the viable healthy cells.  
 It should be noted, however, that the thermal effects are not the only consequences resulting 
from the irradiation of biological tissue by electromagnetic waves in the sub-terahertz frequency 
range [18−21]. Despite the fact that there is an ongoing debate concerning the underlying 
mechanisms of the so called non−thermal (aka athermal) effects, e.g. collective, coherent and 
resonant effects in bio−molecules and living cells a significant knowledge and data has been 
collected on this topic during the recent years. For the current state of the debate see for example 
[15, 22, 23]. At the same time, there is a growing number of experimental evidences 
demonstrating that a local microwave exposure stimulates tissue repair and regeneration, 
mitigates stress reactions and facilitates curing of various diseases, alleviates the effect of X-rays 
etc. [10, 20].  It is clear however that in each particular experimental situation the result of the 
irradiation of the bio-materials with sub−terahertz waves depends on a great number of physical 
factors such as: frequency; field strength; balance between incident, reflected and absorbed 
power; temporal dependence of the wave amplitude (e.g. constant or modulated, CW or 
intermittent pulsed wave), overall duration of the exposure and so on.  The result depends 
strongly also on the physiological characteristics (tissue specific parameters depending on the 
treated organ, blood circulation), ambient environment, geometrical characteristics (e.g. plane or 
curved surface; volume to surface ratio) and many others. Experiments carried out in such 
multidimensional parameter space are difficult to compare and reproduce. Therefore, the only 
way to respond adequately to this problem is a systematic approach, which accounts for all these 
factors and experimental conditions.          
 It is expected that combining two different kinds of radiation therapy, namely the one based on 
irradiation by neutrons (more specifically BCNT) and the other which uses a collimated terahertz 
beam will lead not only to a superposition effect (i.e. an increased efficiency of the treatment due 
to the simultaneous or sequential application of two therapeutic techniques) but also to a synergy 
effect, i.e. effect, which is unique for the above-mentioned combination and could not be 
achieved if the techniques are applied separately. In order to prove this idea experimental 
equipment, which allows combining the irradiation by two beams (neutron and terahertz beam − 
a combination, which we call a quantum beam for short and following the definition given by the 
Japan Atomic Energy Agency Quantum Beam Directorate [24]) is necessary. This motivated us 
to initiate a research project directed towards the development of such hybrid dual−beam 
irradiation facility for an experimental cancer therapy. In this paper we present the conceptual 
design of such system and discuss the further steps of its feasibility study. It is believed that 
building this facility will allow to explore the above mentioned expected effects (superposition 
and synergy) of a novel combined therapy. 
  
2. The gyrotron as a source of coherent terahertz waves for medical applications−current 
status and preceding studies  
 
 Gyrotrons are the most powerful sources of coherent electromagnetic radiation in the sub-
millimeter wavelength region, operating in a CW (continuous wave) regime. In recent years, they 
have demonstrated a remarkable potential for further advancement toward higher (sub−terahertz 
and terahertz) frequencies and are being used in an ever increasing number of applications in the 
basic research and in the technologies [25−27]. In FIR FU, two families of devices namely, 
Gyrotron FU Series and Gyrotron FU CW Series covering a wide range from sub−THz to THz 
frequencies have been developed [26]. Their main characteristics and achievements are 
summarized in the Table 1 and Table 2. The tubes belonging to the FU Series are operated in a 
pulsed regime, while these from the FU CW Series generate a CW radiation. The most recently 
developed devices extend the FU CW Series to two novel branches, namely FU CW C and FU 
CW G, where the specification “C” stands for compact, and “G” for a gyrotron producing a 
Gaussian output beam in an internal mode converter. Some of these gyrotrons have operational 
characteristics and output parameters that are appropriate for experiments on novel medical 
technologies utilizing irradiation by microwaves and have already been used in some preceding 
similar studies.  
 The idea to use microwave (sub−Terahertz) radiation generated by a sub−millimeter wave 
gyrotron for treatment of cancerous cells has been pursued in a number of pioneering studies in 
the FIR FU Research Center [28−31]. During these investigations important issues (e.g. means 
for transmission of the radiation and its application to the treated area through a catheter antenna) 
have been worked out in detail. They have demonstrated clearly the following important 
advantageous features of the irradiation by sub-millimeter waves: (i) it is possible to localize the 
radiation to a small size spot on the living body tissue by the use of a waveguide vent antenna 
and Teflon rod antenna; (ii) increased absorption of the wave power because of the decreased 
reflections in the impedance-matching (anti−reflecting) dielectric layers at the used frequency 
range [32−34]; (iii) millimeter and sub−millimeter waves can be transmitted into the living body 
by a slim catheter; (iv) the dose of the deposited energy can be controlled easily by controlling  
Table 1. Gyrotron FU series  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Gyrotron FU CW series 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
allows even better spatial resolution (smaller spot size) and a treatment localized in a thinner 
surface layer [35]. Promising results, reported recently demonstrate the capabilities of a therapy, 
Gyrotron Frequency, 
THz 
Characteristic features and achievements                          
(The applications are distinguished by italic letters) 
FU I 0.038−0.220 First high-frequency medium power gyrotron of the FU Series. Output 
power of 9 kW at 100 GHz. 
FU E 0.090−0.300 Radiation source for the first experiment on ESR 
FU IA 0.038−0.215 Radiation source for plasma diagnostic at WT−3 
FU II 0.070−0.402 Studies on mode interactions (competition, cooperation etc.). Radiation 
source for plasma scattering measurements at CHS in NIFS. Radiation 
source for XDMR experiments at ESRF.  
FU III 0.100−0.636 3rd harmonic single-mode operation. Amplitude modulation. Frequency 
step switching  
FU IV 0.160−0.847 Frequency modulation. CW operation during long time periods with a 
high stability of the output power and frequency. Medical studies. 
FU IVA 0.160−0.889 Highest frequency at third harmonic (a world record for a long period). 
Radiation source for ESR experiments.  
FU V 0.186−0.222 CW operation for a long time using He−free superconducting magnet. 
High stability of the frequency and the amplitude. High mode purity 
ti  FU VI 0.064−0.137 Large−orbit gyrotron (LOG) with a permanent magnet. High harmonic 
operation up to 5th harmonic of the cyclotron frequency.  
    
Gyrotron Frequency 
range, THz 
Power, 
W 
Max. 
B ,  T 
Characteristic features and 
achievements 
FU CWI 0.300 2300 12 Advanced materials processing. Novel medical 
technologies. 
FU CW II        
FU CW IIA 
0.110−0.440 20−200 8 DNP−NMR at 600 MHz for protein research at Osaka University. Heating of Si substrate. 
Preliminary experiment on Bloch oscillation. 
FU CW III 0.130−1.080 10−220 20 High−power THz technologies 
FU CW IV 0.131−0.139 5−60 10 DNP-NMR at 200 MHz for analysis of polymer 
surface. 
FU CW V 0.2034 100−200 8 Measurement of the hyper−fine splitting (HFS) of positronium. Radiation source for novel 
medical technologies. 
FU CW VI 0.393−0.396 50−100 15 DNP−NMR at 600 MHz for protein research at 
Osaka University. 
FU CW VII 0.2037; 0.3953 200;50 CW 9.2 DNP−NMR at 300 and 600 MHz at Warwick 
University. 
FU CW VIIA 0.1315 0.395 200 8 ESR echo experiment in the sub-THz region. 
FU CW VIII 0.100−0.350 100 8 Pump and probe technique for XDMR at ESRF 
 
precisely the output power of the gyrotron in a real time and measuring the reflected power from 
the tissue. Going to higher frequencies (terahertz beam instead of a millimeter wave beam), 
which is a combination of a hyperthermia treatment using gyrotron and a photodynamic 
treatment (PDT) with a photosensitizer and a laser for irradiation of an experimental tumor 
model [36]. 
 A typical experimental set−up of the preceding bio−medical experiments carried out in FIR FU 
is shown in Fig. 1. In this particular example the gyrotron FU IV was used as a radiation source 
for irradiation of a living tissue. It has a 12 T superconducting magnet and covers a wide 
frequency range from 199 GHz to 305 GHz, producing output powers of up to 20 W at the 
fundamental resonance of the cyclotron frequency.  The radiation is transmitted through a 
cylindrical waveguide with an inner diameter of 28 mm and two bends and then to the catheter 
waveguide by a tapered waveguide section. The catheter waveguide is coupled to one or another 
antenna (waveguide vent antenna, WVA; Teflon rod dielectric antenna; conical horn antenna 
etc.).  During the irradiation, the surface temperature is measured by an infrared radiation 
thermometer in order to estimate the energy absorbed in the tissue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
Fig.1. Experimental setup for millimeter wave irradiation of biological samples and invasion into 
living bodies using a gyrotron as a radiation source (adapted from [30]).   
 
 
3. Conceptual design study of the hybrid dual−beam irradiation facility 
 
 A schematic block diagram and a functional scheme of the hybrid irradiation facility, which 
combines a neutron beam and a terahertz wave in a quantum beam, is shown in Fig. 2. Since the 
so-called dual beam is a result of the coalescence of two beams another appropriate term 
(alongside with a quantum beam) could be a coalescent beam.   
 
 The main components of the envisaged hybrid system are: (i) an accelerator and a neutron 
source; (ii) a gyrotron tube generating coherent terahertz radiation and a system for delivering 
the radiation to the treated zone of the patient’s body consisting of a waveguide transmission 
system and a catheter antenna; (iii) systems for monitoring and control of the parameters of both 
the neutron and the terahertz beams; (iv) a diagnostic system for monitoring and control of the 
doses of irradiation; (v) a system for monitoring of the boron level in the blood of the patient as 
well as other bio−chemical parameters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Hybrid dual−beam irradiation facility: main components and a functional scheme 
 
3.1. Simulation tools used for the conceptual computer aided design (CAD) of the main 
components 
 
 For a computer aided design (CAD) and an optimization of the neutron source and of the 
shielding (radiation protection) the code PHITS (Particle and Heavy Ion Transport code System) 
[37] is used. PHITS simulates the transport of neutrons, protons, heavy particles and photons. 
This advanced software package is also used for simulation of the energy distribution and doses 
to organs of voxel phantoms by the Monte Carlo method [38, 39]. As an example, Fig. 3 shows a 
3D view and dose distribution in a voxel phantom calculated by PHITS. A treatment planning 
system for BNCT called JCDS is incorporated in PHITS as a Monte Carlo transport code.  JCDS 
stands for JAEA (Japan Atomic Energy Agency) Computational Dosimetry System [40, 41]. 
The scheme of the treatment planning using JCDS is illustrated in Fig. 4. It uses both CT 
(computer tomography) and MRI (magnetic resonance imaging) data for a precise evaluation of 
the absorbed radiation. Therefore, PHITS allows one to determine accurately the total doses 
received by the patient as a result of a combined modality therapy such as BNCT and X-ray 
therapy.  
 
 At FIR FU Research Center a problem-oriented software package GYROSIM (which stands for 
Gyrotron Simulation) has been developed for analysis, optimization and CAD of powerful high-
frequency gyrotrons operating in a CW (continuous wave) mode and generating coherent 
radiation in the sub-terahertz and the terahertz frequency range. It is based on adequate and self-
consistent physical models [42], implemented in highly portable and extensible numerical codes 
using efficient algorithms and programming techniques [43]. The structure of the package is 
shown in Fig. 5. Its components are specialized to the simulation of the main subsystems of the 
gyrotron tube, namely: (i) the electron−optical system (EOS), which forms a high-quality helical 
(or uni−axial, in the case of a large orbit gyrotron) electron beam with appropriate parameters; 
(ii) the electro−dynamical system (resonant cavity) in which the electron beam interacts with the 
high−frequency electromagnetic field and radiates a wave beam; and (iii) a quasi−optical system 
for converting the radiation to a Gaussian beam and its transmission to the target. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 3D view produced by PHITS (left), and dose distribution in the voxel phantom (right); 
available online at: http://phits.jaea.go.jp/AppsRaBNCT.html 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Use of the JCDS for a treatment planning based on CT (computer tomography) and MRI 
(magnetic resonance imaging) data [40].  
 
  
 
  
 The process of the CAD of a gyrotron tube carried out using GYROSIM software package is 
shown in Fig.6. It includes several steps and optimization loops, repeated iteratively until a 
satisfactory configuration of the electrodes of the magnetron injection gun (MIG), magnetic field 
profile; shape and dimensions of the resonant cavity as well as the components of the 
quasi−optical system (beam launcher, mirrors of the mode converter etc.) are obtained.  
 Fig.7 shows some illustrative screen-shots from the numerical experiments carried out using 
GYROSIM package for analysis of different designs of gyrotrons which are under consideration 
as appropriate radiation sources for a dual− beam irradiation system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Structure and content of the problem oriented software package GYROSIM for modeling 
and simulation of gyrotrons.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6 Flow chart of the computer−aided design using the components of the GYROSIM package. 
 
 
 
3.2 Specification of the novel gyrotron and the first prototype  
 
 During the first stage of the feasibility and conceptual design study an appropriate area in the 
parameter space, where the prospective gyrotron for the dual−beam irradiation facility will 
operate has been selected. A specification of this radiation source is shown in Table 3. The main 
targeted parameters are the output frequency and the output power. The selected central 
frequency of 395 GHz corresponds to a wavelength of 0.76 mm, i.e. belongs to the 
sub−millimeter range. We however envisage an operation on a sequence of modes, and, as a 
result, frequency step tunability in a wide band around each frequency. This will allow us to use 
both millimeter and sub−millimeter waves in the conceived medical experiments with a quantum 
beam.  
  
 
 
 
Figure 7 Illustrative examples from numerical experiments carried out using the software 
package GYROSIM: Trajectory analysis code GUN-MIG/CUSP (upper panel); single mode 
cavity code SMCC, and multimode time−dependent cavity code MMTDCC (middle panel); 
geometrical optics and analytical ray tracing code GOART (lower panel).   
 It should be noted that the output power levels are deliberately selected higher than those usually 
considered as necessary for a microwave irradiation in this spectral range. One reason for such a 
selection is that the transmission losses could vary significantly depending on the length of the 
system, and thus an adequate reserve of output power must be guaranteed. In any case, an 
attenuating section of the catheter waveguide is always present in the envisaged design and the 
power could be easily decreased if necessary. Having such relatively high output powers 
however, permits experimenting not only with  low intensity irradiation but also with high 
intensity one. Recall that the power densities in the range 0.1−1 mW/cm2 are regarded as 
non−thermal (i.e. not causing heating of the bio−medium of more than 0.1 K). The estimates 
cited in [9] show that a specific absorption rate (SAR) of 1 W/kg produces an increase of 1 °C in 
a human body, taking the thermoregulation into account. The data of other similar experiments 
summarized in [9] indicate also that the pulsed fields are able to produce a detectable change of 
the temperature at lower power levels than the continuous wave (CW).  
 Another consideration concerning the power level is related to the type of the application of the 
microwave energy. There are two varieties of the applicators, namely invasive and noninvasive 
ones. In the case of the noninvasive applicator (i.e. an applicator which does not penetrate the 
body and has not a contact with the tissue) the necessary power is generally higher due to the 
coupling loses. Since we plan to use both types in the experiments, the output power level in the 
specification (Table 3) is set according to the method which demands higher powers.     
 
Table 1 Main requirements and specifications of the gyrotron as a radiation source for the dual− 
beam irradiation facility 
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Mandatory 
 
Description of the requirements 
 
Appropriate range/solution 
 
• Output power at the vacuum window  
• Power at the applicator 
• Central frequency 
• Low accelerating voltage Ua and 
beam current Ib 
• Well collimated Gaussian beam 
• Effective coupling to the applicator 
 
• High stability of the output power 
• Stability of the frequency 
• Easy maintenance 
 
20-30 W 
10-15 W 
395 GHz  (second harmonic) 
Ua=12-15 kV;  
Ib=150-250 mA 
Internal mode converter 
Transmission line with a 
corrugated waveguide 
±1 mW 
10 ppm 
Cryo-free superconducting magnet 
(Bmax=8 T) and computer control 
of the operational parameters 
 
                                                                                       
 
Desirable 
 
• Frequency step tunability 
 
• Amplitude modulation 
 
Control of the magnetic field in the 
cavity 
Feedback controlled beam current , 
voltage,  and magnetic field of the 
MIG 
 For the concept under consideration, the possibility to irradiate the treated living tissue by an 
amplitude modulated sub−terahertz beam is an interesting opportunity. It is planned to study the 
difference (and possibly the advantages) of such a treatment as differ from the case of a constant 
wave. A technique for an amplitude modulation of the gyrotron output has been investigated in 
detail in a series of preceding experiments [44-45]. It is based on the changes of the pitch factor 
(velocity ratio) of the helical electron beam by controlling the anode voltage. Thus, a sub−system 
for both stabilization and modulation of the anode voltage based on a feed back control will be 
realized as a part of the overall control system of the tube.   
 As a whole, the development of this gyrotron follows our concepts (as described in [46]) for 
both innovative and standard designs of novel tubes using the available simulation tools for CAD 
outlined above. The selected tube type (from the nomenclature of the possible standard designs) 
is a sealed-off tube with a triode MIG and a regular cylindrical resonant cavity. An indispensible 
part of it is the internal mode converter which forms a well collimated Gaussian−like wave beam 
at the output window that is suitable for coupling with a low−loss corrugated waveguide of the 
transmission line. The tube will operate at both the fundamental and the second harmonic 
resonances of the cyclotron frequency on a number of modes (thus allowing a step tunability), 
including an excitation of a sequence of high−order axial modes for a continuous frequency 
tunability by controlling the magnetic field in the cavity.  
 The first prototype of such a tube has already been constructed at FIR FU. This gyrotron (FU 
CW CI) is one of newest members of the FU CW series and was conceived initially as a compact 
radiation source for DNP/NMR spectroscopy [26, 47].  Its operational characteristics are 
appropriate also for the planed dual-beam irradiation. Currently, the device is being tested, 
refurbished and prepared for commissioning to the neutron beam facility in the Takasaki site of 
JAEA. Its general view is shown in Fig. 8. FU CW CI is built using a cryogen-free 
superconducting magnet with maximum intensity of the magnetic field of 8 T. The total length of 
the tube (end-to-end) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 Photo of the gyrotron FU CW C I (pre−prototype of the radiation source) 
 
is only 1.02 m. Such compact and lightweight (almost table−top and portable) device could be 
easily embedded in the experimental irradiation facility. Initial experiments have shown that at a 
magnetic field of 7.2 T a single-mode operation on TE26+ takes place at the second harmonic of 
the cyclotron frequency producing radiation with a frequency of 394.6 GHz. Several other modes 
have also been excited both at the fundamental and at the second harmonic operation.   
 
4. Further development of the necessary simulation tools for CAD of a hybrid dual−beam 
system for a radiation therapy  
 
 As already mentioned in the previous section, the available design tools (physical models and 
numerical codes) proved to be adequate for designing the two subsystems (for the neutron 
therapy and for the terahertz therapy) separately, following the principle of the decomposition. 
At the same time however, it should be noticed that the overall performance of the whole facility 
will depend strongly on the interplay between these two parts. That is why, the final design of 
both of them should proceed in parallel and in an iterative way till all target parameters are 
reached and all physical constrains are satisfied. 
 Bearing in mind that the two components of the quantum beam, namely the neutron beam and 
the terahertz beam are of different physical nature (corpuscular one and wave one, 
correspondingly) it is clear that such a task is not a trivial one. This applies specifically to the 
calculation of the total energy deposition in which both contributions (that of the neutron beam 
and that of the terahertz beam) have to be taken into account. Since the two beams are not 
interacting, they could, in principle, propagate through the space in overlapping regions without 
any interference. Due to their different nature however, the methods used for beam control and 
transport are also completely different. In the case of a terahertz beam produced by a gyrotron 
the transmission system and the beam propagation are usually analyzed from the point of view of 
the quasi-optical approach. In order to take into account the diffraction, which could influence 
strongly the radiation pattern of the antenna, either a full-wave treatment or a model based on the 
uniform geometrical theory of diffraction (UTD)  (which is an extension of the geometrical 
theory of diffraction, GTD) must be used. At present, the development of such codes is in 
progress but the finalization of this work demands considerable resources (man power and time). 
 On the current stage of the project, which is a feasibility study preceding the final design of the 
whole system the following tasks are considered as essential ones for continuation of the 
development of the experimental facility: (i) Formulate a physical model for simulation of the 
radiation field and energy deposition in the targeted (irradiated) region produced as a result of 
the irradiation by a terahertz beam and implement this code as a module of the GYROSIM 
package. As a tentative working name for this module we will use the acronym 
TERAGYROBEAM; (ii) Conduct numerical experiments for testing and benchmarking of the 
developed module (TERAGYROBEAM) as well as for accumulation of data (data base) that 
characterize the correlation between the beam parameters and the distribution of both the 
reflected and the absorbed energy using different applicators and antennae; (iii) Interface 
TERAGYROBEAM with PHITS and develop a computational module (in PHITS) for 
calculation of the total energy distribution produced as a result of the simultaneous irradiation by 
the neutron and the terahertz beam as well as for evaluation of an equivalent (effective or 
biological) dose; (iv) Perform a series of numerical experiments using GYROSIM and PHITS 
for an optimized CAD of the components of the hybrid dual−beam system; (vi) Optimize the 
first prototype (FU CW CI) and manufacture a pilot version of a dedicated gyrotron for the 
hybrid irradiation system with an improved (turnkey) operational performance.  
 
5. Conclusions and outlook 
 
 The outlined collaborative research project (and, in fact, interdisciplinary one) is focused on the 
realization of a unique and promising hybrid dual−beam irradiation system for advanced clinical 
studies on novel techniques for cancer treatment (malignant brain tumors, skin cancer etc.) 
utilizing a quantum beam.  It has two main parts, namely a neutron source and a gyrotron 
producing a terahertz beam as well as a number of other auxiliary subsystems for monitoring and 
control of the irradiation process. The available simulation tools (physical models and numerical 
codes), for development of sub−terahertz and terahertz gyrotrons and neutron beam sources as 
well as for analysis of both the propagation and the interaction of the generated beams with the 
target have been used in this feasibility study in order to produce an initial conceptual design. 
Based on it, the first pre−prototype of the gyrotron has been developed and manufactured. Some 
tasks for further development of the codes that are necessary for an optimized final design of the 
whole irradiation facility have been formulated as well. 
 It should be mentioned that the terahertz beam produced by the gyrotron could be used not only 
for treatment of the irradiated tissue but also for microwave imaging and diagnostics [15, 48, 49]. 
In the modern therapeutic techniques the imaging (e.g. MRI, computer tomography etc.) is 
indispensible for detection and diagnostics, especially for the emerging image guided radiation 
therapy (IGRT) [50]. Therefore we plan to explore such possibilities and possibly integrate them 
in the next versions of the design. 
 It is believed that building such novel irradiation facility will open many new opportunities for 
experimenting with different therapeutic techniques utilizing a quantum beam and will facilitate 
the development of effective methods and tools for a cancer treatment. 
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